Press "Enter" to skip to content

Nuclear Medicine Radioisotopes Market Size 2019 – Growing Demand Status of Top Manufacturers with Industry Share, Size, Projection, Consumption Forecast to 2024


The “Nuclear Medicine Radioisotopes Market” report 2019 provides information for market players, stakeholders, investors, and business strategists to achieve a leading position the market. It maintains the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Nuclear Medicine Radioisotopes market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Nuclear Medicine Radioisotopes market is provided in detail in the report.

Get a Sample Copy of the Report –  

Nuclear Medicine Radioisotopes Market Covers Key Players:

  • Agfa
  • Gevaert Group
  • Cardiarc Ltd
  • Digirad Corporation
  • CMR Naviscan (Gamma Medica Inc.)
  • GE Healthcare
  • Positron Corp.
  • Segami Corporation
  • Siemens Healthcare GmBH
  • Nordion (Canada) Inc.
  • NTP Radioisotopes SOC Ltd
  • Bracco S.p.A
  • Cardinal Health Inc.
  • Curium

    Market Overview:

  • Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.

    Report Highlights:

    • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    • Market forecasts till 2024, using estimated market values as the base numbers
    • Key market trends across the business segments, Regions and Countries
    • Key developments and strategies observed in the market
    • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    • In-depth company profiles of key players and upcoming prominent players
    • Growth prospects among the emerging nations through 2024
    • Nuclear Medicine Radioisotopes Market opportunities and recommendations for new investments

    For More Information or Query or Customization Before Buying, Visit at

    Scope of the Report:

  • As per the , medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.

    Key Market Trends:

    Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.

    North America captured the Largest Market Share and is Expected to Retain its Dominance

    North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.

    Purchase this Report (Price 4250 USD for single user license) –

    Detailed TOC of Nuclear Medicine Radioisotopes Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Incidences of Cancer and Cardiac Disorders
    4.2.2 Widening Applications of Nuclear Medicine
    4.2.3 Increasing SPECT and PET Applications
    4.2.4 Increasing Patient Awareness for Healthcare
    4.3 Market Restraints
    4.3.1 Reimbursement Complications
    4.3.2 Regulatory Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Type of Radioisotopes
    5.1.1 Technetium-99m (Tc-99m)
    5.1.2 Thallium-201 (Tl-201)
    5.1.3 Iodine (I-123)
    5.1.4 Fluorine-18
    5.1.5 Rubidium-82 (Rb-82)
    5.1.6 Iodine-131 (I-131)
    5.1.7 Lutetium-177 (Lu-177)
    5.1.8 Radium-223 (Ra-223) & Alpharadin
    5.1.9 Actinium-225 (Ac-225)
    5.1.10 Others
    5.2 Application
    5.2.1 Oncology
    5.2.2 Cardiology
    5.2.3 Lymphoma
    5.2.4 Thyroid
    5.2.5 Neurology
    5.2.6 Other Applications
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Rest of the World

    6.1 Company Profiles
    6.1.1 Agfa-Gevaert Group
    6.1.2 Cardiarc Ltd
    6.1.3 Digirad Corporation
    6.1.4 CMR Naviscan (Gamma Medica Inc.)
    6.1.5 GE Healthcare
    6.1.6 Positron Corp.
    6.1.7 Segami Corporation
    6.1.8 Siemens Healthcare GmBH
    6.1.9 Nordion (Canada) Inc.
    6.1.10 NTP Radioisotopes SOC Ltd
    6.1.11 Bracco S.p.A
    6.1.12 Cardinal Health Inc.
    6.1.13 Curium



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Functional Apparel Market Size and Share 2019 | Global Industry Analysis By Trends, Future Demands, Growth Factors, Emerging Technologies, Prominent Players and Forecast Till 2024

    Global Solar Outdoor LED Lighting Market Share, Size 2019 Movements by Development Analysis, Progression Status, Revenue Expectation to 2024 | Research Report by Industry Research Biz

    Polyethylene Market Analysis 2019 – Global Industry Size, Growth Rate, Top Key Players, Market Consumption, Sales Forecast to 2024

    Tadalafil Market 2019 – Driving Factors of Key Players, Emerging Technologies, Sales Revenue, Global Size, Share, and Forecast to 2023

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *